BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TNF-Kinoid: Phase IIb started

Neovacs began the double-blind, placebo-controlled, international Phase IIb TNF-K-006 trial to evaluate 300 µg/mL intramuscular TNF-Kinoid in about 140 patients with active RA despite methotrexate therapy.

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >